home / stock / aplt / aplt quote
Last: | $ |
---|---|
Change Percent: | -0.38% |
Open: | $52.94 |
Close: | $52.80 |
High: | $54.00 |
Low: | $51.52 |
Volume: | 114,734 |
Last Trade Date Time: | 02/12/2020 04:42:20 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $52.94 | $52.80 | $54.00 | $51.52 | 114,734 | 02-12-2020 |
$ | $53.98 | $53.00 | $54.62 | $50.40 | 193,303 | 02-11-2020 |
$ | $53.74 | $53.78 | $55.151 | $52.5272 | 234,302 | 02-10-2020 |
$ | $50.31 | $53.95 | $54.60 | $50.01 | 539,310 | 02-07-2020 |
$ | $55.88 | $51.26 | $56.0772 | $51.05 | 185,608 | 02-06-2020 |
$ | $55.46 | $55.47 | $56.85 | $54.7091 | 116,145 | 02-05-2020 |
$ | $55.13 | $54.70 | $57.39 | $54.16 | 196,951 | 02-04-2020 |
$ | $53.22 | $54.01 | $55.751 | $53.22 | 296,484 | 02-03-2020 |
$ | $55.11 | $52.47 | $55.85 | $52.1079 | 174,045 | 01-31-2020 |
$ | $50.20 | $53.13 | $53.27 | $49.32 | 178,360 | 01-30-2020 |
$ | $49.71 | $49.60 | $52.9895 | $49.06 | 156,796 | 01-29-2020 |
$ | $50.63 | $49.83 | $50.63 | $48.66 | 108,797 | 01-28-2020 |
$ | $48.76 | $50.32 | $50.82 | $47.42 | 241,447 | 01-27-2020 |
$ | $49.10 | $48.66 | $52.46 | $47.2801 | 912,351 | 01-24-2020 |
$ | $48.00 | $48.85 | $51.00 | $47.0206 | 208,925 | 01-23-2020 |
$ | $48.01 | $47.93 | $49.98 | $46.00 | 178,415 | 01-22-2020 |
$ | $47.99 | $48.35 | $53.16 | $46.87 | 133,066 | 01-21-2020 |
$ | $50.00 | $48.86 | $50.89 | $48.50 | 107,646 | 01-20-2020 |
$ | $50.00 | $48.86 | $50.89 | $48.50 | 107,371 | 01-17-2020 |
$ | $44.88 | $48.29 | $48.6974 | $44.88 | 154,157 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Applied Therapeutics Inc. Company Name:
APLT Stock Symbol:
NYSE Market:
Applied Therapeutics Inc. Website:
NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will participate i...
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company developing a p...
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the appointment of Dale ...